We are dedicated to pioneering innovative therapies that address the complexities of neurodegenerative and rare diseases.
Anavex is built on the expertise and dedication of a diverse team of professionals who are redefining what’s possible in therapeutic development.
Our team is comprised of world-class scientists, clinicians, and leaders dedicated to advancing innovative therapies for neurodegenerative and rare diseases.
CNS disorders impact people of all ages and backgrounds. From infants to the elderly, we are committed to solving these devastating conditions, all of which do not yet have a suitable treatment option.
We are united by a shared mission to develop innovative therapies for neurodegenerative and rare diseases. Our work is fueled by curiosity, collaboration, and a deep commitment to science that makes a difference. Join us in shaping the future of healthcare and transforming lives through precision medicine.
Every person is unique. As a result, we aspire to develop therapeutic treatments that are tailored to suit each individual’s unique medical condition.
Patients and carers are the experts of the conditions that impact their lives. As a result, we value and rely on community-based partnerships to inform our decision making and strategy development processes.
Our therapeutic development model is designed to identify and innovate novel therapeutic solutions that are rooted in science.
There is a global institutional need for change and we are committed to serving the naturally diverse human population and to the implementation of inclusive and equitably accessible therapeutic programs.
